VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $277,000 | +53.9% | 11,900 | 0.0% | 0.03% | +55.6% |
| Q1 2018 | $180,000 | -27.7% | 11,900 | 0.0% | 0.02% | -28.0% |
| Q4 2017 | $249,000 | +46.5% | 11,900 | 0.0% | 0.02% | +8.7% |
| Q3 2017 | $170,000 | -17.9% | 11,900 | 0.0% | 0.02% | -25.8% |
| Q2 2017 | $207,000 | +58.0% | 11,900 | 0.0% | 0.03% | +55.0% |
| Q1 2017 | $131,000 | +244.7% | 11,900 | +357.7% | 0.02% | +185.7% |
| Q4 2016 | $38,000 | +375.0% | 2,600 | +550.0% | 0.01% | +250.0% |
| Q2 2016 | $8,000 | -27.3% | 400 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $11,000 | -72.5% | 400 | 0.0% | 0.00% | -70.0% |
| Q4 2015 | $40,000 | -43.7% | 400 | 0.0% | 0.01% | -47.4% |
| Q3 2015 | $71,000 | -93.3% | 400 | -91.7% | 0.02% | -92.5% |
| Q2 2015 | $1,067,000 | +28.6% | 4,800 | +14.3% | 0.25% | +25.9% |
| Q1 2015 | $830,000 | +315.0% | 4,200 | +250.0% | 0.20% | +252.6% |
| Q4 2014 | $200,000 | +153.2% | 1,200 | +100.0% | 0.06% | +159.1% |
| Q3 2014 | $79,000 | -55.4% | 600 | -57.1% | 0.02% | -48.8% |
| Q2 2014 | $177,000 | -25.3% | 1,400 | -22.2% | 0.04% | -27.1% |
| Q1 2014 | $237,000 | -34.9% | 1,800 | -41.9% | 0.06% | -37.9% |
| Q4 2013 | $364,000 | +24.2% | 3,100 | +10.7% | 0.10% | +14.5% |
| Q3 2013 | $293,000 | +21.6% | 2,800 | 0.0% | 0.08% | +18.6% |
| Q2 2013 | $241,000 | – | 2,800 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |